COVID-19 in Children with Congenital Heart Diseases: A Multicenter Case Series from Iran
Background. Promptly discovering and counteracting COVID-19 is critical as it could have catastrophic effects. As an asymptomatic group, children are highly susceptible to be misdiagnosed, especially those suffering from underlying diseases. Furthermore, discriminating the direct effects of the viru...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Case Reports in Pediatrics |
Online Access: | http://dx.doi.org/10.1155/2021/6690695 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832550536149204992 |
---|---|
author | Hassan Esmaeeli Mehdi Ghaderian Keyhan Sayadpour Zanjani Seyyedeh Fatemeh Ghalibafan Mehrzad Mahdizadeh Mohammad Hassan Aelami |
author_facet | Hassan Esmaeeli Mehdi Ghaderian Keyhan Sayadpour Zanjani Seyyedeh Fatemeh Ghalibafan Mehrzad Mahdizadeh Mohammad Hassan Aelami |
author_sort | Hassan Esmaeeli |
collection | DOAJ |
description | Background. Promptly discovering and counteracting COVID-19 is critical as it could have catastrophic effects. As an asymptomatic group, children are highly susceptible to be misdiagnosed, especially those suffering from underlying diseases. Furthermore, discriminating the direct effects of the virus from those of the underlying diseases can pose a dilemma to physicians. This case series aims to determine the relationship between COVID-19 and various types of congenial heart disease among children. Patients and Methods. Seven patients from three different medical centers were enrolled. Their detailed demographic information, past medical history, symptoms, type of congenital heart diseases, imaging tests, laboratory tests, medications, and outcomes were analyzed. Results. The patients included 4 infants, 1 child, and 2 adolescents, with a median age of 9 months and a majority of boys. All of them had either obstructive lesions (right or left ventricular outflow tracts) or significant pulmonary hypertension. The more common clinical symptoms were cough, dyspnea, and fever. Two patients did not survive the illness. Conclusion. Prompt treatment of patients with a combination of COVID-19 and severe obstructive cardiac pathology or pulmonary hypertension is essential due to a risk for serious and/or fatal consequences. |
format | Article |
id | doaj-art-120b9ee38725491bb266d0a52e2e8ccc |
institution | Kabale University |
issn | 2090-6803 2090-6811 |
language | English |
publishDate | 2021-01-01 |
publisher | Wiley |
record_format | Article |
series | Case Reports in Pediatrics |
spelling | doaj-art-120b9ee38725491bb266d0a52e2e8ccc2025-02-03T06:06:31ZengWileyCase Reports in Pediatrics2090-68032090-68112021-01-01202110.1155/2021/66906956690695COVID-19 in Children with Congenital Heart Diseases: A Multicenter Case Series from IranHassan Esmaeeli0Mehdi Ghaderian1Keyhan Sayadpour Zanjani2Seyyedeh Fatemeh Ghalibafan3Mehrzad Mahdizadeh4Mohammad Hassan Aelami5Cardiology Department, School of Medicine, Gorgan University of Medical Sciences, Gorgan, IranPediatric Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, IranCardiology Division, Pediatric Department, Children’s Medical Center (Pediatric Center of Excellence), Tehran University of Medical Sciences, Tehran, IranMashhad University of Medical Sciences, Mashhad, IranRadiology Division, Children’s Medical Center (Pediatric Center of Excellence), Tehran University of Medical Sciences, Tehran, IranDepartment of Pediatrics and Hand Hygiene and Infection Control Research Center, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, IranBackground. Promptly discovering and counteracting COVID-19 is critical as it could have catastrophic effects. As an asymptomatic group, children are highly susceptible to be misdiagnosed, especially those suffering from underlying diseases. Furthermore, discriminating the direct effects of the virus from those of the underlying diseases can pose a dilemma to physicians. This case series aims to determine the relationship between COVID-19 and various types of congenial heart disease among children. Patients and Methods. Seven patients from three different medical centers were enrolled. Their detailed demographic information, past medical history, symptoms, type of congenital heart diseases, imaging tests, laboratory tests, medications, and outcomes were analyzed. Results. The patients included 4 infants, 1 child, and 2 adolescents, with a median age of 9 months and a majority of boys. All of them had either obstructive lesions (right or left ventricular outflow tracts) or significant pulmonary hypertension. The more common clinical symptoms were cough, dyspnea, and fever. Two patients did not survive the illness. Conclusion. Prompt treatment of patients with a combination of COVID-19 and severe obstructive cardiac pathology or pulmonary hypertension is essential due to a risk for serious and/or fatal consequences.http://dx.doi.org/10.1155/2021/6690695 |
spellingShingle | Hassan Esmaeeli Mehdi Ghaderian Keyhan Sayadpour Zanjani Seyyedeh Fatemeh Ghalibafan Mehrzad Mahdizadeh Mohammad Hassan Aelami COVID-19 in Children with Congenital Heart Diseases: A Multicenter Case Series from Iran Case Reports in Pediatrics |
title | COVID-19 in Children with Congenital Heart Diseases: A Multicenter Case Series from Iran |
title_full | COVID-19 in Children with Congenital Heart Diseases: A Multicenter Case Series from Iran |
title_fullStr | COVID-19 in Children with Congenital Heart Diseases: A Multicenter Case Series from Iran |
title_full_unstemmed | COVID-19 in Children with Congenital Heart Diseases: A Multicenter Case Series from Iran |
title_short | COVID-19 in Children with Congenital Heart Diseases: A Multicenter Case Series from Iran |
title_sort | covid 19 in children with congenital heart diseases a multicenter case series from iran |
url | http://dx.doi.org/10.1155/2021/6690695 |
work_keys_str_mv | AT hassanesmaeeli covid19inchildrenwithcongenitalheartdiseasesamulticentercaseseriesfromiran AT mehdighaderian covid19inchildrenwithcongenitalheartdiseasesamulticentercaseseriesfromiran AT keyhansayadpourzanjani covid19inchildrenwithcongenitalheartdiseasesamulticentercaseseriesfromiran AT seyyedehfatemehghalibafan covid19inchildrenwithcongenitalheartdiseasesamulticentercaseseriesfromiran AT mehrzadmahdizadeh covid19inchildrenwithcongenitalheartdiseasesamulticentercaseseriesfromiran AT mohammadhassanaelami covid19inchildrenwithcongenitalheartdiseasesamulticentercaseseriesfromiran |